REFERENCES
- Scott I U, Lieb D F, Flynn H W, et al. Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcomes of treatment. Arch Ophthalmol 2003; 121: 573–576, [PUBMED], [INFOTRIEVE], [CSA]
- Ehlers S. Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?. Clin Infect Dis 2005; 41(Suppl 3)S199–S203, [INFOTRIEVE], [CROSSREF], [CSA]
- Deepe G S, jr, Smelt S, Louie J S. Tumor necrosis factor inhibition and opportunistic infections. Clin Infect Dis 2005; 41(Suppl 3)S187–S188, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hyrich K L, Silman A J, Watson K D, Symmons D PM. Anti-tumour necrosis factor α therapy in rheumatoid arthritis: an update on safety. Ann Rheum Dis 2004; 63: 1538–1543, [INFOTRIEVE], [CROSSREF], [CSA]
- Kroesen S, Widmer A F, Tyndall A, Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) 2003; 42: 617–621, [CROSSREF], [CSA]
- Ellerin T, Rubin R H, Weinblatt M E. Infections and anti-tumor necrosis factor α therapy. Arthritis Rheum 2003; 48: 3013–3021, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113: 1479–1496, [CSA]
- Campochiaro P A, Conway B P. Aminoglycoside toxicity—a survey of retinal specialists: implications for ocular use. Arch Ophthalmol 1991; 109: 946–950, [PUBMED], [INFOTRIEVE], [CSA]
- Unal M, Peyman G A, Liang C, et al. Ocular toxicity of intravitreal clarithromycin. Retina 1999; 19: 442–446, [INFOTRIEVE], [CROSSREF], [CSA]
- Axelrod J L, Newton J C, Klein R M, et al. Penetration of imipenem into human aqueous and vitreous humor. Am J Ophthalmol 1997; 104: 649–653, [CSA]
- Al-Sibai M B, Al-Kaff A S, Raines D, El-Yaziqi A. Ocular penetration of oral clarithromycin in humans. J Ocul Pharmacol Ther 1998; 14: 575–583, [INFOTRIEVE], [CSA]
- Hyon J -Y, Joo M -J, Hose S, et al. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Arch Ophthalmol 2004; 122: 1166–1169, [INFOTRIEVE], [CROSSREF], [CSA]
- Freitas D, Alvarenga L, Sampaio J, et al. An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology 2003; 110: 276–285, [INFOTRIEVE], [CROSSREF], [CSA]
- Wilhelmus K R. Nontuberculous mycobacterial endophthalmitis [Correspondence]. Arch Ophthalmol 2003; 121: 1663, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]